Purine Pharmaceuticals Inc.
Gillette, NJ · Biotech · Private
Recombinant human E-NTPDase (hENTPD3-ECD) therapeutic protein to prevent ischemia-reperfusion injury in hemorrhagic shock
- Grants
- $1.7M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620172018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Soluble E-NTPDase for sepsis | $224,871 | |
| Federal grant | Department of Health and Human Services · Phase I · A2A receptor blockade for sepsis | $223,820 | |
| Federal grant | Department of Health and Human Services · Phase I · CD73 for sepsis | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Intravenous ivermectin for sepsis | $193,829 | |
| Federal grant | Department of Health and Human Services · Phase I · A2B receptor stimulation for sepsis | $226,287 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Recombinant E-NTPDase for shock | $299,999 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Recombinant E-NTPDase for shock | $299,999 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1274 | SYNSPIRA THERAPEUTICS, INC. | — | — |
| 1275 | NANOTHERAPEUTICS, INC. | — | — |
| 1276 | FIBROPLATE INC | — | — |
| 1277 | Purine Pharmaceuticals Inc. | — | — |
| 1278 | EDITPEP INC | — | $8.2M |
| 1279 | DNATWO, INC. | — | — |
| 1280 | ASYMMETREX, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.